115 related articles for article (PubMed ID: 7932560)
1. (E)-3-[[[[6-(2-carboxyethenyl)-5-[[8-(4- methoxyphenyl)octyl]oxy]-2-pyridinyl]-methyl]thio]methyl]benzoic acid and related compounds: high affinity leukotriene B4 receptor antagonists.
Daines RA; Chambers PA; Eggleston DS; Foley JJ; Griswold DE; Haltiwanger RC; Jakas DR; Kingsbury WD; Martin LD; Pendrak I
J Med Chem; 1994 Sep; 37(20):3327-36. PubMed ID: 7932560
[TBL] [Abstract][Full Text] [Related]
2. In vitro and in vivo pharmacological characterization of SB 201993, an eicosanoid-like LTB4 receptor antagonist with anti-inflammatory activity.
Sarau HM; Foley JJ; Schmidt DB; Martin LD; Webb EF; Tzimas MN; Breton JJ; Chabot-Fletcher M; Underwood DC; Hay DW; Kingsbury WD; Chambers PA; Pendrak I; Jakas DR; Sathe GM; Van Horn S; Daines RA; Griswold DE
Prostaglandins Leukot Essent Fatty Acids; 1999 Jul; 61(1):55-64. PubMed ID: 10477044
[TBL] [Abstract][Full Text] [Related]
3. (E)-3-[6-[[(2,6-dichlorophenyl)thio]methyl]-3-(2-phenylethoxy)-2- pyridinyl]-2-propenoic acid: a high-affinity leukotriene B4 receptor antagonist with oral antiinflammatory activity.
Daines RA; Chambers PA; Foley JJ; Griswold DE; Kingsbury WD; Martin LD; Schmidt DB; Sham KK; Sarau HM
J Med Chem; 1996 Sep; 39(19):3837-41. PubMed ID: 8809171
[TBL] [Abstract][Full Text] [Related]
4. (E)-3-[[[[6-(2-carboxyethenyl)-5-[[8-(4- methoxyphenyl)octyl]oxy]-2-pyridinyl]-methyl]thio]methyl]benzoic acid: a novel high-affinity leukotriene B4 receptor antagonist.
Daines RA; Chambers PA; Pendrak I; Jakas DR; Sarau HM; Foley JJ; Schmidt DB; Griswold DE; Martin LD; Tzimas MN
J Med Chem; 1993 Sep; 36(18):2703-5. PubMed ID: 8410983
[No Abstract] [Full Text] [Related]
5. Trisubstituted pyridine leukotriene B4 receptor antagonists: synthesis and structure-activity relationships.
Daines RA; Chambers PA; Pendrak I; Jakas DR; Sarau HM; Foley JJ; Schmidt DB; Kingsbury WD
J Med Chem; 1993 Oct; 36(22):3321-32. PubMed ID: 8230122
[TBL] [Abstract][Full Text] [Related]
6. Synthetic and structure/activity studies on acid-substituted 2-arylphenols: discovery of 2-[2-propyl-3-[3-[2-ethyl-4-(4-fluorophenyl)-5- hydroxyphenoxy]-propoxy]phenoxy]benzoic acid, a high-affinity leukotriene B4 receptor antagonist.
Sawyer JS; Bach NJ; Baker SR; Baldwin RF; Borromeo PS; Cockerham SL; Fleisch JH; Floreancig P; Froelich LL; Jackson WT
J Med Chem; 1995 Oct; 38(22):4411-32. PubMed ID: 7473568
[TBL] [Abstract][Full Text] [Related]
7. Synthesis of structural analogs of leukotriene B4 and their receptor binding activity.
Kingsbury WD; Pendrak I; Leber JD; Boehm JC; Mallet B; Sarau HM; Foley JJ; Schmidt DB; Daines RA
J Med Chem; 1993 Oct; 36(22):3308-20. PubMed ID: 8230121
[TBL] [Abstract][Full Text] [Related]
8. Pharmacologic actions of the second-generation leukotriene B4 receptor antagonist LY293111: in vitro studies.
Jackson WT; Froelich LL; Boyd RJ; Schrementi JP; Saussy DL; Schultz RM; Sawyer JS; Sofia MJ; Herron DK; Goodson T; Snyder DW; Pechous PA; Spaethe SM; Roman CR; Fleisch JH
J Pharmacol Exp Ther; 1999 Jan; 288(1):286-94. PubMed ID: 9862783
[TBL] [Abstract][Full Text] [Related]
9. Blockade of human neutrophil activation by 2-[2-propyl-3-[3-[2-ethyl-4-(4-fluorophenyl)-5- hydroxyphenoxy]propoxy]phenoxy]benzoic acid (LY293111), a novel leukotriene B4 receptor antagonist.
Marder P; Sawyer JS; Froelich LL; Mann LL; Spaethe SM
Biochem Pharmacol; 1995 May; 49(11):1683-90. PubMed ID: 7786309
[TBL] [Abstract][Full Text] [Related]
10. New serine protease inhibitors with leukotriene B4 (LTB4) receptor binding affinity.
Nakayama Y; Senokuchi K; Sakaki K; Kato M; Maruyama T; Miyazaki T; Ito H; Nakai H; Kawamura M
Bioorg Med Chem; 1997 May; 5(5):971-85. PubMed ID: 9208106
[TBL] [Abstract][Full Text] [Related]
11. Characterization of the pharmacological profile of the potent LTB4 antagonist CP-105,696 on murine LTB4 receptors in vitro.
Showell HJ; Breslow R; Conklyn MJ; Hingorani GP; Koch K
Br J Pharmacol; 1996 Mar; 117(6):1127-32. PubMed ID: 8882606
[TBL] [Abstract][Full Text] [Related]
12. trans-3-Benzyl-4-hydroxy-7-chromanylbenzoic acid derivatives as antagonists of the leukotriene B4 (LTB4) receptor.
Reiter LA; Koch K; Piscopio AD; Showell HJ; Alpert R; Biggers MS; Chambers RJ; Conklyn MJ; Cooper K; Cortina SR; Dibrino JN; Dominy BW; Farrell CA; Hingorani GP; Martinelli GJ; Ramchandani M; Wright KF
Bioorg Med Chem Lett; 1998 Jul; 8(14):1781-6. PubMed ID: 9873433
[TBL] [Abstract][Full Text] [Related]
13. The leukotriene B4 receptor agonist/antagonist activities of SC-45694 in human neutrophils.
Tsai BS; Keith RH; Villani-Price D; Haack RA; Djuric SW
J Pharmacol Exp Ther; 1994 Mar; 268(3):1493-8. PubMed ID: 8138959
[TBL] [Abstract][Full Text] [Related]
14. Trisubstituted benzene leukotriene B4 receptor antagonists: synthesis and structure-activity relationships.
Konno M; Nakae T; Sakuyama S; Odagaki Y; Nakai H; Hamanaka N
Bioorg Med Chem; 1997 Aug; 5(8):1649-74. PubMed ID: 9313868
[TBL] [Abstract][Full Text] [Related]
15. ONO-4057, a novel, orally active leukotriene B4 antagonist: effects on LTB4-induced neutrophil functions.
Kishikawa K; Tateishi N; Maruyama T; Seo R; Toda M; Miyamoto T
Prostaglandins; 1992 Oct; 44(4):261-75. PubMed ID: 1332129
[TBL] [Abstract][Full Text] [Related]
16. SB 209247, a high affinity LTB4 receptor antagonist demonstrating potent antiinflammatory activity.
Sarau HM; Foley JJ; Schmidt DB; Tzimas MN; Martin LD; Daines RA; Chambers PA; Kingsbury WD; Griswold DE
Adv Prostaglandin Thromboxane Leukot Res; 1995; 23():275-7. PubMed ID: 7732852
[No Abstract] [Full Text] [Related]
17. Differential effects of 20-trifluoromethyl leukotriene B4 on human neutrophil functions.
Tsai BS; Keith RH; Villani-Price D; Haack RA; Bauer RF; Leonard R; Abe Y; Nicolaou KC
Prostaglandins; 1989 Feb; 37(2):287-302. PubMed ID: 2543037
[TBL] [Abstract][Full Text] [Related]
18. Leukotriene B4 (LTB4) receptor antagonists: a series of (hydroxyphenyl)pyrazoles.
Harper RW; Jackson WT; Froelich LL; Boyd RJ; Aldridge TE; Herron DK
J Med Chem; 1994 Jul; 37(15):2411-20. PubMed ID: 8057289
[TBL] [Abstract][Full Text] [Related]
19. omega-[(4,6-Diphenyl-2-pyridyl)oxy]alkanoic acid derivatives: a new family of potent and orally active LTB4 antagonists.
Labaudinière R; Dereu N; Cavy F; Guillet MC; Marquis O; Terlain B
J Med Chem; 1992 Nov; 35(23):4315-24. PubMed ID: 1333012
[TBL] [Abstract][Full Text] [Related]
20. The effects of LY293111Na, a leukotriene B4 receptor antagonist, on the pulmonary neutrophilia and CD11b expression caused by inhalation of a leukotriene B4 aerosol in rhesus monkeys.
Allen DL; Hoffman WP; Marder P; Matchett MR; Leiter PA; Abbott DL; Wolff RK
J Pharmacol Exp Ther; 1996 Apr; 277(1):341-9. PubMed ID: 8613940
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
